Nea Management Company
$1.8B Assets Reported
28 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ACLX | Arcellx, Inc. | 3,045,262 | $350M | 19.9% |
| CELC | Celcuity Inc. | 2,285,561 | $261M | 14.8% |
| SGP | Spyglass Pharma, Inc. | 7,392,301 | $192M | 10.9% |
| TRVI | Trevi Therapeutics, Inc. | 13,222,228 | $158M | 9.0% |
| SVRA | Savara, Inc. | 24,471,264 | $134M | 7.6% |
| GLUE | Monte Rosa Therapeutics, Inc. | 7,692,298 | $127M | 7.2% |
| MBX | MBX Biosciences, Inc. | 3,614,486 | $108M | 6.1% |
| ZBIO | Zenas BioPharma, Inc. | 4,023,219 | $79M | 4.5% |
| COUR | Coursera, Inc. | 12,867,769 | $75M | 4.3% |
| AUPH | Aurinia Pharmaceuticals, Inc. | 3,969,834 | $59M | 3.3% |
Track Nea Management Company's 13F portfolio: $1.8B in reported holdings, 28 positions. Top holdings, AUM, and quarterly changes on SentiSense.